190 related articles for article (PubMed ID: 16053358)
21. Transrectal high-intensity focused ultrasound: minimally invasive therapy of localized prostate cancer.
Gelet A; Chapelon JY; Bouvier R; Rouvière O; Lasne Y; Lyonnet D; Dubernard JM
J Endourol; 2000 Aug; 14(6):519-28. PubMed ID: 10954310
[TBL] [Abstract][Full Text] [Related]
22. Local recurrence of prostate cancer after external beam radiotherapy: early experience of salvage therapy using high-intensity focused ultrasonography.
Gelet A; Chapelon JY; Poissonnier L; Bouvier R; Rouvière O; Curiel L; Janier M; Vallancien G
Urology; 2004 Apr; 63(4):625-9. PubMed ID: 15072864
[TBL] [Abstract][Full Text] [Related]
23. High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer.
Cordeiro ER; Cathelineau X; Thüroff S; Marberger M; Crouzet S; de la Rosette JJ
BJU Int; 2012 Nov; 110(9):1228-42. PubMed ID: 22672199
[TBL] [Abstract][Full Text] [Related]
24. High-intensity focused ultrasound in prostate cancer: results after 3 years.
Chaussy C; Thüroff S
Mol Urol; 2000; 4(3):179-82. PubMed ID: 11062372
[TBL] [Abstract][Full Text] [Related]
25. [Treatment of prostatic cancer with high intensity focused ultrasound (HIFU) using Ablatherm device].
Aliaev IuG; Krupinov GE; Bezrukov EA; Grigorian VA; Amosov AV; Chalyĭ ME; Kobzev DN; Bruk IuF; Shestiperov PA
Urologiia; 2007; (6):39-44. PubMed ID: 18649659
[TBL] [Abstract][Full Text] [Related]
26. Locally recurrent prostate cancer after initial radiation therapy: early salvage high-intensity focused ultrasound improves oncologic outcomes.
Crouzet S; Murat FJ; Pommier P; Poissonnier L; Pasticier G; Rouviere O; Chapelon JY; Rabilloud M; Belot A; Mège-Lechevallier F; Tonoli-Catez H; Martin X; Gelet A
Radiother Oncol; 2012 Nov; 105(2):198-202. PubMed ID: 23068708
[TBL] [Abstract][Full Text] [Related]
27. [Transrectal high-intensity focused ultrasound with the Sonablate 500 for the treatment of prostate cancer].
Lu J; Chen ZY; Wang W; Zhang YF; Qiu XF; Zhang LC; Hu WL; Xu WF; Ye ZQ
Zhonghua Nan Ke Xue; 2007 Nov; 13(11):1005-8. PubMed ID: 18077913
[TBL] [Abstract][Full Text] [Related]
28. Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: a preliminary report.
Uchida T; Sanghvi NT; Gardner TA; Koch MO; Ishii D; Minei S; Satoh T; Hyodo T; Irie A; Baba S
Urology; 2002 Mar; 59(3):394-8; discussion 398-9. PubMed ID: 11880077
[TBL] [Abstract][Full Text] [Related]
29. Five years experience of transrectal high-intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer.
Uchida T; Ohkusa H; Yamashita H; Shoji S; Nagata Y; Hyodo T; Satoh T
Int J Urol; 2006 Mar; 13(3):228-33. PubMed ID: 16643614
[TBL] [Abstract][Full Text] [Related]
30. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.
Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G
BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973
[TBL] [Abstract][Full Text] [Related]
31. Control of prostate cancer by transrectal HIFU in 227 patients.
Poissonnier L; Chapelon JY; Rouvière O; Curiel L; Bouvier R; Martin X; Dubernard JM; Gelet A
Eur Urol; 2007 Feb; 51(2):381-7. PubMed ID: 16857310
[TBL] [Abstract][Full Text] [Related]
32. [High-intensity focussed ultrasound in low-risk prostate cancer - oncological outcome and postinterventional quality of life of an inexperienced therapy centre in comparison with an experienced therapy centre].
Baumunk D; Andersen C; Heile U; Ebbing J; Cash H; Porsch M; Liehr UB; Janitzky A; Wendler JJ; Schindele D; Blaschke S; Miller K; Schostak M
Aktuelle Urol; 2013 Jul; 44(4):285-92. PubMed ID: 23888408
[TBL] [Abstract][Full Text] [Related]
33. Hemi salvage high-intensity focused ultrasound (HIFU) in unilateral radiorecurrent prostate cancer: a prospective two-centre study.
Baco E; Gelet A; Crouzet S; Rud E; Rouvière O; Tonoli-Catez H; Berge V; Chapelon JY; Eggesbø HB
BJU Int; 2014 Oct; 114(4):532-40. PubMed ID: 24930692
[TBL] [Abstract][Full Text] [Related]
34. Location of residual cancer after transrectal high-intensity focused ultrasound ablation for clinically localized prostate cancer.
Boutier R; Girouin N; Cheikh AB; Belot A; Rabilloud M; Gelet A; Chapelon JY; Rouvière O
BJU Int; 2011 Dec; 108(11):1776-81. PubMed ID: 21711432
[TBL] [Abstract][Full Text] [Related]
35. [High-intensity focused ultrasound (HIFU) for the prostate cancer treatment: 5-year resuts].
Shaplysin LV; Solov VA; Vosdvizhenskiĭ MO; Khametov RZ
Urologiia; 2013; (1):70-2. PubMed ID: 23662500
[TBL] [Abstract][Full Text] [Related]
36. Salvage high-intensity focused ultrasound for biopsy-confirmed local recurrence of prostate cancer after radical prostatectomy.
Murota-Kawano A; Nakano M; Hongo S; Shoji S; Nagata Y; Uchida T
BJU Int; 2010 Jun; 105(12):1642-5. PubMed ID: 19922544
[TBL] [Abstract][Full Text] [Related]
37. Transrectal high-intensity focused ultrasound using the Ablatherm device in the treatment of localized prostate carcinoma.
Beerlage HP; Thüroff S; Debruyne FM; Chaussy C; de la Rosette JJ
Urology; 1999 Aug; 54(2):273-7. PubMed ID: 10443724
[TBL] [Abstract][Full Text] [Related]
38. Single-session primary high-intensity focused ultrasonography treatment for localized prostate cancer: biochemical outcomes using third generation-based technology.
Pinthus JH; Farrokhyar F; Hassouna MM; Woods E; Whelan K; Shayegan B; Orovan WL
BJU Int; 2012 Oct; 110(8):1142-8. PubMed ID: 22372721
[TBL] [Abstract][Full Text] [Related]
39. Experience with high-intensity focused ultrasound therapy for management of organ-confined prostate cancer: critical evaluation of oncologic outcomes.
Komura K; Inamoto T; Masuda H; Watsuji T; Azuma H
Acta Biomed; 2012 Dec; 83(3):189-96. PubMed ID: 23762994
[TBL] [Abstract][Full Text] [Related]
40. Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience.
Gelet A; Chapelon JY; Bouvier R; Souchon R; Pangaud C; Abdelrahim AF; Cathignol D; Dubernard JM
Eur Urol; 1996; 29(2):174-83. PubMed ID: 8647143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
